Abstract
The Ebola virus disease (EVD) outbreak, which was declared as such in West Africa inMarch 2014, has become the largest EVD epidemic to date. It is the first time that EVD has beenresponsible for cases imported to the US as well as locally-acquired cases in Europe. Researchon pathophysiology and treatment has been considerably accelerated, and more precise des-criptions of various forms of ocular involvement have been obtained. Conjunctival hyperemiais often present during the acute phase, and it may contribute to the diagnosis of EVD in anepidemic context. During convalescence, ocular inflammatory manifestations may develop andcan be caused by viral persistence in ocular tissue. Eye care providers need to be aware of theophthalmic manifestations of EVD, sometimes several weeks after the acute infection, in orderto recognize them and take appropriate safety precautions.
| Translated title of the contribution | Ocular manifestations of Ebola virus disease: What we learned from the last epidemic |
|---|---|
| Original language | French |
| Pages (from-to) | 758-763 |
| Number of pages | 6 |
| Journal | Journal Francais d'Ophtalmologie |
| Volume | 38 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 1 Oct 2015 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Ocular manifestations of Ebola virus disease: What we learned from the last epidemic'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver